Journal rankings · indicator year 2007
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2007
Pharmacology, Toxicology and Pharmaceutics journal rankings 2007
38 ranked journals · Field in Life Sciences
Pharmacology, Toxicology and Pharmaceutics has 38 ranked journals in 2007. The median OJR rose 0.20 on 2006 to 1.11, above the world average of 1.00; Q1 starts at OJR 1.63. The top three are Current Drug Metabolism, Critical Reviews in Therapeutic Drug Carrier Systems, and Pharmacogenetics.
Ranks and citation indicators: 2007. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2004–2006, the window the 2007 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Pharmacology, Toxicology and Pharmaceutics (4)
Up to Life Sciences38 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2006. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2004–2006, the window the 2007 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2004–2006 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2007. | Compare |
|---|---|---|---|---|---|---|---|
1Current Drug MetabolismBentham Science Publishers · Netherlands | 2.83Q1 | 4.87 0.98 down from 2006 | 162 | 8% | — | ||
2Critical Reviews in Therapeutic Drug Carrier SystemsBegell House · United States | 2.67Q1 | 2.72 3.36 down from 2006 | 39 | 5% | — | ||
3PharmacogeneticsLippincott Williams & Wilkins · United Kingdom | 2.60Q1 | —no 2006 value | 95 | — | — | ||
4Pharmacogenetics and GenomicsLippincott Williams & Wilkins · United Kingdom | 2.56Q1 | 5.71 0.53 down from 2006 | 209 | 14% | — | ||
5The Pharmacogenomics JournalSpringer Nature · United Kingdom | 2.12Q1 | 4.67 0.58 up from 2006 | 196 | 15% | $4,890 | ||
6Drug Metabolism and DispositionAmerican Society for Pharmacology and Experimental Therapeutics · United States | 1.88Q1 | 3.54 0.55 down from 2006 | 829 | 6% | $3,500 | ||
7Pharmaceutical ResearchSpringer Science+Business Media · United States | 1.80Q1 | 3.66 0.30 up from 2006 | 869 | 17% | $4,690 | ||
8Drug SafetyAdis, Springer Healthcare · New Zealand | 1.72Q1 | 2.55 2.09 down from 2006 | 394 | 1% | $4,990 | ||
9Expert Opinion on Drug DeliveryTaylor & Francis · United Kingdom | 1.66Q1 | 3.36 1.17 up from 2006 | 161 | 3% | — | ||
10European Journal of Pharmaceutical SciencesOAElsevier BV · Netherlands | 1.63Q1 | 3.02 0.81 up from 2006 | 565 | 4% | $3,070 | ||
11Expert Opinion on Drug Metabolism & ToxicologyTaylor & Francis · United Kingdom | 1.61Q2 | 3.27 1.89 up from 2006 | 118 | 6% | — | ||
12European Journal of Pharmaceutics and BiopharmaceuticsElsevier BV · Netherlands | 1.58Q2 | 2.42 0.21 down from 2006 | 548 | 6% | $4,210 | ||
13PharmacogenomicsFuture Medicine · United Kingdom | 1.52Q2 | 3.41 0.19 up from 2006 | 309 | 7% | — | ||
14Current Drug DeliveryBentham Science Publishers · Netherlands | 1.52Q2 | 2.90 0.79 up from 2006 | 138 | 0% | — | ||
15International Journal of PharmaceuticsElsevier BV · Netherlands | 1.47Q2 | 2.52 0.08 up from 2006 | 1,676 | 5% | $4,650 | ||
16Expert Opinion on Drug SafetyTaylor & Francis · United Kingdom | 1.38Q2 | 2.92 0.27 up from 2006 | 252 | 1% | — | ||
17Drug Metabolism and PharmacokineticsElsevier BV · Japan | 1.33Q2 | 2.84 0.03 up from 2006 | 173 | 3% | $3,580 | ||
18Journal of Analytical ToxicologyOxford University Press · United Kingdom | 1.33Q2 | 2.68 0.68 up from 2006 | 356 | 32% | $4,823 | ||
19Drug DeliveryOATaylor & Francis · United Kingdom | 1.14Q2 | 1.59 0.20 down from 2006 | 158 | 99% | $2,864 | ||
20XenobioticaTaylor & Francis · United Kingdom | 1.08Q3 | 2.06 0.21 up from 2006 | 238 | 2% | — | ||
21AAPS PharmSciTechSpringer Science+Business Media · United States | 1.03Q3 | 1.83 0.59 up from 2006 | 266 | 99% | $4,190 | ||
22Journal of MicroencapsulationTaylor & Francis · United Kingdom | 0.96Q3 | 1.55 0.55 up from 2006 | 218 | 3% | — | ||
23Journal of Fluorine ChemistryElsevier BV · Netherlands | 0.81Q3 | 1.35 0.01 down from 2006 | 775 | 5% | $3,660 | ||
24Drug Development and Industrial PharmacyTaylor & Francis · United States | 0.71Q3 | 1.09 0.02 up from 2006 | 386 | 4% | — | ||
25Biopharmaceutics & Drug DispositionWiley · United Kingdom | 0.67Q3 | 1.51 0.46 up from 2006 | 158 | 6% | $3,800 | ||
26Pharmaceutical Development and TechnologyTaylor & Francis · United States | 0.66Q3 | 0.93 0.23 up from 2006 | 194 | 3% | — | ||
27American Journal of Drug DeliverySpringer Science+Business Media · New Zealand | 0.66Q3 | 1.00 0.03 up from 2006 | 65 | — | — | ||
28Assay and Drug Development TechnologiesMary Ann Liebert, Inc. · United States | 0.60Q3 | 1.58 0.06 down from 2006 | 258 | 4% | — | ||
29Journal of Drug Delivery Science and TechnologyElsevier BV · France | 0.38Q3 | 0.65 0.13 down from 2006 | 204 | 0% | $3,810 | ||
30Drug metabolism and drug interactionsDe Gruyter · Germany | 0.38Q4 | 0.50 0.40 down from 2006 | 41 | 0% | — | ||
31YAKUGAKU ZASSHIOAPharmaceutical Society of Japan · Japan | 0.35Q4 | 0.77 0.20 up from 2006 | 392 | 90% | — | ||
32European Journal of Drug Metabolism and PharmacokineticsAdis, Springer Healthcare · France | 0.30Q4 | 0.56 0.03 up from 2006 | 122 | 0% | $2,690 | ||
33Current Drug TherapyBentham Science Publishers · Netherlands | 0.28Q4 | 0.45no 2006 value | 31 | 3% | — | — | |
34Dissolution TechnologiesUnited States | 0.28Q4 | 0.49 0.04 down from 2006 | 72 | 84% | — | ||
35Annales de Toxicologie AnalytiqueElsevier BV · France | 0.15Q4 | 0.23 0.04 down from 2006 | 88 | 90% | $3,140 | ||
36Scientia PharmaceuticaOAÖsterreichische Apotheker-Verlagsgesellschaft m. b. H. · Switzerland | 0.13Q4 | 0.27 0.10 up from 2006 | 63 | 100% | $1,207 | ||
37Journal of Pharmaceutical Marketing & ManagementHaworth Press · United States | 0.12Q4 | 0.04no change | 66 | 0% | — | ||
| 0.03Q4 | 0.06 0.06 up from 2006 | 52 | 100% | — |
Subfields of Pharmacology, Toxicology and Pharmaceutics, compared.
Journals
Citations made in 2007. Corpus-wide, 72.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
15 additional Pharmacology, Toxicology and Pharmaceutics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2004–2006, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2007. Publication window: 2004–2006. How these summaries are calculated
- Ranked journals
- 38
- Window papers (baseline)
- 34,777 +29.3% from indicator year 2004
- Median OJR
- 1.11 +28.5% from indicator year 2004
- Rising journals (2025)
- 4Comparison-group list (4)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2004–2006 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 23 | 27 | 30 | 32 | 32 | 34 | 37 | 38 | 40 | 43 | 44 | 49 | 54 | 61 | 69 | 71 | 74 | 71 | 73 | 75 | 70 | 72 | 75 | 73 | 72 | 68 | |
| Window papers (baseline) | 20,428 | 21,714 | 23,158 | 25,397 | 26,889 | 29,157 | 31,606 | 34,777 | 38,146 | 41,640 | 45,814 | 49,553 | 53,613 | 56,245 | 59,173 | 59,681 | 59,061 | 56,321 | 53,536 | 51,719 | 51,606 | 54,267 | 56,608 | 57,539 | 56,944 | 58,541 | |
| Median OJR | 0.620 | 0.717 | 0.722 | 0.88 | 0.86 | 0.83 | 0.91 | 1.11 | 0.9471 | 0.97 | 0.949 | 1.03 | 0.9469 | 0.80 | 0.70 | 0.720 | 0.61 | 0.7184 | 0.74 | 0.628 | 0.77 | 0.621 | 0.67 | 0.630 | 0.625 | 0.7176 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 2.7% | 62 journals |
| Retracted papers per 1,000 | Pooled rate: 1.221 per 1,000 | 51 journals |
| Output growth | Median: -1.6% | 60 journals |
| Open access share | Median: 44.5% | 68 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,605 | 32 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 22.2% | 67 journals |
| Review share | Median: 0.4% | 68 journals |
| Articles-only OJR | Median: 0.74 | 68 journals |
| Uncited share | Median: 25.2% | 68 journals |
| Citation concentration | Median: 43.7% | 68 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.